Aveanna Healthcare Holdings Inc. (AVAH) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aveanna Healthcare Holdings Inc. (AVAH) opera en el sector Healthcare, cotizado por última vez a $6.35 con una capitalización de mercado de 2B. La acción obtiene una puntuación de 52/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 9 feb 2026Aveanna Healthcare Holdings Inc. (AVAH) Resumen de Asistencia Médica y Tuberías
Aveanna Healthcare (AVAH) offers a compelling investment in the growing home healthcare market, providing diversified services from pediatric care to hospice, capitalizing on the shift towards in-home care and reducing healthcare costs with a patient-centered approach and a 3.3% profit margin.
Tesis de Inversión
Aveanna Healthcare presents a notable research candidate due to its strategic positioning in the expanding home healthcare market. The increasing preference for in-home care, coupled with the rising costs of institutional healthcare, creates a favorable environment for Aveanna's diversified service offerings. With a market capitalization of $1.64 billion and a P/E ratio of 21.74, Aveanna demonstrates solid financial performance. Key value drivers include the growth of its Private Duty Services (PDS) segment, driven by the increasing demand for pediatric home care, and the expansion of its Home Health & Hospice (HHH) segment, capitalizing on the aging population and the desire for end-of-life care at home. The company's Medical Solutions (MS) segment provides a steady revenue stream through the provision of essential medical supplies. Aveanna's patient-centered approach and focus on reducing healthcare costs position it for sustained growth and profitability.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $1.64 billion reflects investor confidence in Aveanna's market position.
- P/E ratio of 21.74 indicates a reasonable valuation relative to earnings.
- Gross margin of 33.5% demonstrates efficient cost management and pricing strategies.
- Profit margin of 3.3% showcases the company's ability to generate profit from its revenue.
- Beta of 2.06 suggests higher volatility compared to the market, potentially offering higher returns but also increased risk.
Competidores y Pares
Fortalezas
- Diversified service offerings across the home healthcare continuum.
- Established reputation for providing high-quality, patient-centered care.
- Strong relationships with managed care organizations and government payers.
- Geographic reach across multiple states in the United States.
Debilidades
- Exposure to regulatory changes and reimbursement pressures.
- Reliance on government funding and managed care contracts.
- Competition from other home healthcare providers.
- Potential for labor shortages and increased labor costs.
Catalizadores
- Ongoing: Increasing demand for home healthcare services due to the aging population.
- Ongoing: Shift towards value-based care models that reward providers for delivering high-quality, cost-effective care.
- Upcoming: Potential for strategic acquisitions to expand geographic reach and service offerings.
- Ongoing: Integration of technology solutions to improve efficiency and patient outcomes.
Riesgos
- Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.
- Ongoing: Increased competition from other home healthcare providers could erode market share.
- Potential: Economic downturns could reduce demand for home healthcare services.
- Ongoing: Labor shortages and increased labor costs could impact profitability.
Oportunidades de crecimiento
- Growth opportunity 1: Expansion of Pediatric Services: The demand for pediatric home healthcare is increasing due to the rising number of children with complex medical needs. Aveanna can capitalize on this trend by expanding its Private Duty Services (PDS) segment, offering specialized nursing care, therapy services, and pediatric day healthcare centers. This market segment is projected to grow at an annual rate of 6-8% over the next five years, presenting a significant opportunity for Aveanna to increase its market share and revenue.
- Growth opportunity 2: Strategic Acquisitions: Aveanna can pursue strategic acquisitions of smaller home healthcare providers to expand its geographic reach and service offerings. By acquiring companies with complementary services or a strong presence in specific regions, Aveanna can accelerate its growth and enhance its competitive position. The home healthcare market is fragmented, providing ample opportunities for consolidation. Successful acquisitions can lead to increased revenue, cost synergies, and improved market penetration.
- Growth opportunity 3: Technology Integration: Investing in technology solutions, such as telehealth platforms and remote patient monitoring systems, can improve the efficiency and effectiveness of Aveanna's services. Telehealth can enable remote consultations, medication management, and patient education, while remote monitoring can provide real-time data on patients' health status. These technologies can enhance patient outcomes, reduce costs, and improve caregiver productivity, driving growth and profitability.
- Growth opportunity 4: Focus on Value-Based Care: As the healthcare industry shifts towards value-based care models, Aveanna can position itself as a leader in delivering high-quality, cost-effective care. By demonstrating improved patient outcomes and reduced healthcare costs, Aveanna can attract contracts with managed care organizations and government payers. This requires investing in data analytics, care coordination, and quality improvement initiatives. Success in value-based care can lead to increased patient volume, higher reimbursement rates, and enhanced brand reputation.
- Growth opportunity 5: Expansion of Hospice Services: With the aging population and the increasing prevalence of chronic diseases, the demand for hospice care is expected to grow significantly. Aveanna can expand its Home Health & Hospice (HHH) segment by offering comprehensive hospice services, including palliative care, pain management, and emotional support for patients and their families. This market segment offers attractive growth opportunities, as hospice care is often reimbursed at higher rates than other home healthcare services.
Oportunidades
- Expansion of services into new geographic markets.
- Strategic acquisitions of smaller home healthcare providers.
- Integration of technology solutions to improve efficiency and patient outcomes.
- Focus on value-based care models to attract contracts with managed care organizations.
Amenazas
- Changes in government regulations and reimbursement policies.
- Increased competition from other home healthcare providers.
- Economic downturns that could reduce demand for home healthcare services.
- Potential for lawsuits and regulatory investigations.
Ventajas competitivas
- Diversified service offerings across the home healthcare continuum.
- Strong relationships with managed care organizations and government payers.
- Established reputation for providing high-quality, patient-centered care.
- Geographic reach across multiple states in the United States.
Acerca de AVAH
Aveanna Healthcare Holdings Inc., established in 2016 and headquartered in Atlanta, Georgia, operates as a diversified home care platform. The company was founded with the mission of providing high-quality, patient-centered care in the comfort of patients' homes, thereby minimizing the need for expensive hospital stays and institutional care. Aveanna's services span a wide spectrum, including private duty nursing (PDN), adult home health and hospice care, home-based pediatric therapy, and enteral nutrition services. These services are delivered through three primary segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment focuses on in-home skilled nursing for medically fragile children, nursing services in schools, pediatric day healthcare centers, and therapy services. The HHH segment provides skilled nursing, therapy, and hospice care to adults. The MS segment supplies enteral nutrition products. Aveanna's commitment to patient-centered care and its diversified service offerings position it as a key player in the evolving healthcare landscape, emphasizing cost-effective and personalized solutions.
Qué hacen
- Provides private duty nursing (PDN) for medically fragile children.
- Offers adult home health and hospice care services.
- Delivers home-based pediatric therapy services, including physical, occupational, and speech therapy.
- Supplies enteral nutrition products to adults and children.
- Operates pediatric day healthcare centers.
- Provides nursing services in school settings.
Modelo de Negocio
- Generates revenue through providing skilled nursing and therapy services in patients' homes.
- Earns income from the sale of enteral nutrition supplies and other medical products.
- Contracts with managed care organizations, government payers, and private insurance companies for reimbursement of services.
- Operates on a fee-for-service basis, with rates varying based on the type and duration of services provided.
Contexto de la Industria
Aveanna Healthcare operates within the growing home healthcare industry, which is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. The market is highly competitive, with players ranging from large national providers to smaller regional and local agencies. Aveanna differentiates itself through its diversified service offerings, encompassing pediatric care, adult home health, and medical solutions. The industry is expected to continue growing at a steady pace, fueled by technological advancements and increasing demand for cost-effective and patient-centered care. Competitors include ACHC (Acadia Healthcare), ADUS (Addus HomeCare), ARDT (Ardent Health Services), ASTH (Ascension Health), and BKD (Brookdale Senior Living), each with varying focuses within the healthcare spectrum.
Clientes Clave
- Medically fragile children requiring skilled nursing care.
- Adults needing home health services, including skilled nursing, therapy, and hospice care.
- Patients requiring enteral nutrition support.
- Families seeking in-home care for their loved ones.
Finanzas
Gráfico e información
Precio de la acción de Aveanna Healthcare Holdings Inc. (AVAH): $6.35 (-0.26, -3.89%)
Últimas noticias
-
Aveanna Healthcare Holdings' (NASDAQ:AVAH) Promising Earnings May Rest On Soft Foundations
Yahoo! Finance: AVAH News · 27 mar 2026
-
Is AUNA S.A. a Solid Investment Opportunity Post Q4 Earnings?
Yahoo! Finance: AVAH News · 26 mar 2026
-
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5
benzinga · 25 mar 2026
-
RBC Capital Maintains Sector Perform on Aveanna Healthcare Hldgs, Lowers Price Target to $9
benzinga · 23 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para AVAH.
Objetivos de Precios
Objetivo de consenso: $10.50
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de AVAH en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Últimas Noticias
Aveanna Healthcare Holdings' (NASDAQ:AVAH) Promising Earnings May Rest On Soft Foundations
Is AUNA S.A. a Solid Investment Opportunity Post Q4 Earnings?
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5
RBC Capital Maintains Sector Perform on Aveanna Healthcare Hldgs, Lowers Price Target to $9
Preguntas Comunes Sobre AVAH
¿Cuáles son los factores clave para evaluar AVAH?
Aveanna Healthcare Holdings Inc. (AVAH) actualmente tiene una puntuación IA de 52/100, indicando puntuación moderada. La acción cotiza a un P/E de 6.0x, por debajo del promedio del S&P 500 (~20-25x), potencialmente señalando valor. Los analistas apuntan a $10.50 (+65% desde $6.35). Fortaleza clave: Diversified service offerings across the home healthcare continuum.. Riesgo principal a monitorear: Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de AVAH?
AVAH actualmente puntúa 52/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de AVAH?
Los precios de AVAH se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre AVAH?
Los analistas han establecido un precio objetivo de consenso de $10.50 para AVAH, representando un potencial alcista del 65% desde el precio actual de $6.35. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en AVAH?
Las categorías de riesgo para AVAH incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de AVAH?
Aveanna Healthcare Holdings Inc. (AVAH) tiene una relación P/E de 6.0, que está por debajo del promedio del mercado, lo que puede sugerir valor relativo. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.
¿Está AVAH sobrevalorada o infravalorada?
Determinar si Aveanna Healthcare Holdings Inc. (AVAH) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 6.0. Objetivo de analistas $10.50 (+65% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de AVAH?
Aveanna Healthcare Holdings Inc. (AVAH) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.